Abstrakt
To this day, myocardial infarction (MI) remains the leading cause of mortality worldwide. While its etiology is multifactorial, anemia – regard less of its underlying cause – may either accompany MI as a comorbid ity or serve as a direct precipitant of myocardial ischemia, particularly in cases of type 2 MI. Importantly, anemia diagnosed at hospital ad mission has been recognized as an independent predictor of adverse cardiovascular outcomes, including both short and longterm mortality, irrespective of its role in the pathogenesis of MI. In the case presented, severe macrocytic anemia caused by vitamin B12 deficiency resulted in acute coronary syndrome without ST-seg ment elevation (NSTE-ACS). Because of typical chest pain and deep STsegment depression in multiple leads, the patient was initially qual ified for urgent coronary angiography. In the meantime, however, mor phology results revealed severe anemia, and a noninvasive strategy was chosen. During hospitalization, the patient’s blood deficiency was corrected, the cause of anemia was identified, and treatment was in itiated. Coronary angiography was performed two months later, once blood counts had normalized, revealing significant stenosis of the distal seg ment of the left main coronary artery (LMCA) and critical ostial stenosis of the left anterior descending artery (LAD). This case report provides a starting point for discussing the optimal timing of coronary angiogra phy in the setting of NSTEACS with concomitant anemia and urges deliberate consideration of any potential delay, as well as followup treatment.
Bibliografia
1. Thygesen K., Alpert J.S., Jaffe A.S. et al.: Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol 2018; 72(18): 2231-2264. doi: 10.1016/j.jacc.2018.08.1038.
2. Padda J., Khalid K., Hitawala G. et al.: Acute anemia and myocardial infarction. Cureus 2021; 13(8): e17096. doi: 10.7759/cureus.17096. 3. Byrne R.A., Rossello X., Coughlan J.J. et al.: 2023 ESC guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J Acute Cardiovasc Care 2024; 13(1): 55-161. doi: 10.1093/ehjacc/zuad107. 4. Collet J.P., Thiele H., Barbato E. et al.: 2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the Task Force for the management of acute coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J 2023; 44: 3720-3826. 5. Colombo M.G., Kirchberger I., Amann U. et al.: Association between admission anemia and long-term mortality in patients with acute myocardial infarction: results from the MONICA/KORA myocardial infarction registry. BMC Cardiovasc Disord 2018; 18(1): 50. doi: 10.1186/s12872-018-0785-5.
6. Franchini M., Marano G., Mengoli C. et al.: Red blood cell transfusion policy: a critical literature review. Blood Transfus 2017; 15(4): 307-317. doi: 10.2450/2017.0059-17.
7. Green R., Dwyre D.M.: Evaluation of macrocytic anemias. Semin Hematol 2015; 52(4): 279-286. doi: 10.1053/j.seminhematol.2015.06.001.
8. Nagao T., Hirokawa M.: Diagnosis and treatment of macrocytic anemias in adults. J Gen Fam Med 2017; 18(5): 200204. doi: 10.1002/jgf2.31. 9. Wagner G.S., Macfarlane P., Wellens H. et al.: AHA/ACCF/ HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram: Part VI: Acute Ischemia/ Infarction: A Scientific Statement From the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol 2009; 53(11): 1003-1011. doi: 10.1016/j.jacc.2008.12.016. 10. Liu Y., Yang Y.M., Zhu J. et al.: Anaemia and prognosis in acute coronary syndromes: a systematic review and meta-analysis. J Int Med Res 2012; 40(1): 43-55. doi: 10.1177/147323001204000105.
11. Sudarsky D. et al.: Impact of early invasive approach on outcomes of patients with acute coronary syndrome and baseline anemia: analysis from the ACSIS registry. J Interv Cardiol 2015; 28(4): 315-325. doi: 10.1111/joic.12216. 12. Ducrocq G. et al.: Effect of a restrictive vs liberal blood transfusion strategy on major cardiovascular events among patients with acute myocardial infarction and anemia: the REALITY randomized clinical trial. JAMA 2021; 325(6): 552560. doi: 10.1001/jama.2021.0135.

Utwór dostępny jest na licencji Creative Commons Uznanie autorstwa – Użycie niekomercyjne – Na tych samych warunkach 4.0 Międzynarodowe.
Prawa autorskie (c) 2026 Review of Medical Practice
